Glenn Van Hulst
3PUBLICATIONS
2CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (3)
Sort by Publication Date:
|Jul 01, 2022
Reply: Ex vivo SOCS3 gene responsiveness to alarmins in eosinophils of mepolizumab-treated patients is as yet of unknown biological significance.Glenn Van Hulst, Joseph Jorssen, Nathalie Jacobs
|Sep 28, 2021
Eosinophils as Drivers of Severe Eosinophilic Asthma: Endotypes or Plasticity?Glenn Van Hulst, Fabrice Bureau, Christophe J Desmet
|Sep 03, 2021
Anti-IL5 mepolizumab minimally influences residual blood eosinophils in severe asthma.Glenn Van Hulst, Joseph Jorssen, Nathalie Jacobs
Pageof 1
